Embecta (EMBC) Cash & Current Investments (2022 - 2026)
Embecta (EMBC) reported Cash & Current Investments of $193.4 million for Q1 2026, down 8.9% on a YoY basis from $212.3 million in Q1 2025, and down 5.38% sequentially from $204.4 million in Q4 2025.
Embecta (EMBC) Cash & Current Investments (2022 - 2026) Analysis & Trends
Embecta (EMBC) has 5 years of Cash & Current Investments data on file, last reported at $193.4 million in Q1 2026.
- For the quarter ending Q1 2026, Cash & Current Investments fell 8.9% year-over-year to $193.4 million; the trailing twelve-month figure through Mar 2026 stood at $193.4 million (down 8.9% YoY), and the FY2025 full-year result was $228.6 million, down 16.63% from the prior year.
- Cash & Current Investments fell to $193.4 million in Q1 2026, from $204.4 million in the prior quarter.
- In the past five years, Cash & Current Investments ranged from a high of $385.2 million in Q4 2022 to a low of $193.4 million in Q1 2026.
- A 5-year average of $277.2 million and a median of $281.8 million in 2024 frame the typical range for Cash & Current Investments.
- Across the five-year window, Cash & Current Investments surged 31.06% in 2023 and sank 30.73% in 2025, its largest moves.
- Tracing EMBC's Cash & Current Investments over 5 years: stood at $385.2 million in 2022, then decreased by 22.46% to $298.7 million in 2023, then fell by 27.45% to $216.7 million in 2024, then declined by 5.68% to $204.4 million in 2025, then slipped by 5.38% to $193.4 million in 2026.
- Business Quant data shows EMBC's Cash & Current Investments at $193.4 million in Q1 2026, $204.4 million in Q4 2025, and $228.6 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Current Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 126.32 Bn | 121.10 Bn | 1.96 Bn | 5.22 Bn |
| 2 | Becton Dickinson | 44.69 Bn | 43.88 Bn | 2.15 Bn | 816.00 Mn |
| 3 | Alcon | 32.80 Bn | 31.14 Bn | 1.53 Bn | 1.66 Bn |
| 4 | Medline | 32.72 Bn | 30.49 Bn | 1.84 Bn | 2.24 Bn |
| 5 | Resmed | 29.54 Bn | 27.88 Bn | 890.98 Mn | 1.66 Bn |
| 6 | West Pharmaceutical Services | 23.56 Bn | 23.13 Bn | 329.20 Mn | 435.80 Mn |
| 7 | Solventum | 14.00 Bn | 13.44 Bn | 1.10 Bn | 561.00 Mn |
| 8 | Cooper Companies | 13.75 Bn | 13.61 Bn | 735.40 Mn | 138.80 Mn |
| 9 | Align Technology | 12.03 Bn | 10.97 Bn | 736.59 Mn | 1.06 Bn |
| 10 | Embecta | 204.88 Mn | 11.48 Mn | 127.80 Mn | 193.40 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 193.40 Mn |
| Dec 31, 2025 | 204.40 Mn |
| Sep 30, 2025 | 228.60 Mn |
| Jun 30, 2025 | 233.60 Mn |
| Mar 31, 2025 | 212.30 Mn |
| Dec 31, 2024 | 216.70 Mn |
| Sep 30, 2024 | 274.20 Mn |
| Jun 30, 2024 | 281.80 Mn |
| Mar 31, 2024 | 306.50 Mn |
| Dec 31, 2023 | 298.70 Mn |
| Sep 30, 2023 | 326.50 Mn |
| Jun 30, 2023 | 317.40 Mn |
| Mar 31, 2023 | 346.40 Mn |
| Dec 31, 2022 | 385.20 Mn |
| Sep 30, 2022 | 330.90 Mn |
| Jun 30, 2022 | 292.30 Mn |
| Mar 31, 2022 | 264.30 Mn |